Surely that cannot go on very long
Comparing Your Options Patients often inquire about how Foundayo compares to options like Zepbound or Wegovy
In addition to the well-established benefits of CR, multiple studies have demonstrated that during intermittent fasting (IF), neurons undergo an adaptive response mediated by elevated BDNF levels, which enhance neuronal resilience and plasticity in response to metabolic stress 40,41,42

Emerging Therapy Retatrutide Retatrutide is a new emerging (LY-3437943) is a triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors currently under trial conducted by Eli Lilly and Company Mechanism of Action GIP agonism enhances insulin release, suppresses appetite, inhibits fat accumulation GLP-1 agonism enhances insulin release, suppresses glucagon, slows gastric emptying Glucagon receptor agonism boosts energy expenditure, supports glycemic control Collectively, it addresses glucose homeostasis, appetite regulation, energy metabolism, and weight loss Competitive Edge over Existing Therapies Superior efficacy: Around 24% weight loss surpasses GLP-1-only treatments (e.g., semaglutide, tirzepatide)